Provision of pain management by a pharmacist with prescribing authority

American Journal of Health-System Pharmacy

Volumn 64, Issue 1, 2007, Pages 85-89

  Dole, Ernest J ^a,b,f   Murawski, Matthew M ^c   Adolphe, Allen B ^b,d   Aragon, Frances D ^e   Hochstadt, Barry ^a  

^a Internal Medicine   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c PURDUE UNIVERSITY   (United States)

^d Gibson LMG   (United States)

^e PFIZER INC   (United States)

^f Lovelace Medical Group   (United States)

Author keywords

Ambulatory care; Clinical pharmacists; Economics; Interventions; Outcomes; Pain; Pharmaceutical services; Prescribing; Reimbursement

Indexed keywords

AMBULATORY CARE; ANALGESIA; ARTICLE; CHRONIC PAIN; COST CONTROL; FEE; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; LAW; PAIN CLINIC; PHARMACIST; PRESCRIPTION; PRESCRIPTIVE AUTHORITY; PRIORITY JOURNAL; UNITED STATES; VISUAL ANALOG SCALE;

EID: 33947149049     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060056     Document Type: Article

References (21)

1. Merenich JA, Lousberg TR, Brennan SH et al. Optimizing treatment of dyslipidemia in patients with coronary artery disease in a managed-care environment (the Rocky Mountain Kaiser Permanente experience). Am J Cardiol 2000; 85:36A-42A.
2. Leape LL, Cullen DJ, Clapp MD et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999; 282:267-70. [Erratum, JAMA. 2000; 283:1293.]
3. Bond CA, Monson R. Sustained improvement in drug documentation, compliance, and disease control. A four-year analysis of an ambulatory care model. Arch Intern Med. 1984; 144:1159-62.
4. Jameson J, VanNoord G, Vanderwoud K. The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy. J Fam Pract. 1995; 41:469-72.
5. McMullin ST, Hennenfent JA, Ritchie DJ et al. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med. 1999; 159:2306-9.
6. Hanlon JT, Weinberger M, Samsa GP et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996; 100:428-37.
7. Gattis WA, Hasselblad V, Whellan DJ et al. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med. 1999; 159:1939-45.
8. Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med. 1995; 155:1949-56.
9. Bond CA, Raehl CL, Franke T. Interrelationships among mortality rates, drug costs, total cost of care and length of stay in United States hospitals: summary and recommendations for clinical pharmacy services and staffing. Pharmacotherapy. 2001; 21:129-41.
10. Carmichael JM, O'Connell MB, Devine B et al. Collaborative drug therapy management by pharmacists. Pharmacotherapy. 1997; 17:1050-61.
11. Schumock GT, Butler MG, Meek PD et al. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy. 2003; 23:113-32.
12. Lipton HL, Bird JA. The impact of clinical pharmacists' consultations on geriatric patients' compliance and medical care use: a randomized controlled trial. Gerontologist. 1994;34:307-15.
13. Rupp MT. Performing and billing for cognitive services: implications for the US. Ann Pharmacother. 2000; 34:401-2.
14. Keely JL, for the American College of Physicians-American Society of Internal Medicine. Pharmacist scope of practice. Ann Intern Med. 2002; 136:79-85.
15. Hammond RW, Dole EJ. The pharmacist clinician: prescriptive authority in New Mexico. J Manag Care Pharm. 1996; 2:594-6.
16. Dole EJ. Profession of second lieutenants. Am J Health-Syst Pharm. 2002; 59:558-60.
17. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), www.nhlbi. nih.gov/guidelines/ cholesterol/atp3full.pdf (accessed 2006 Mar 15).
18. VHA/DoD clinical practice guidelines for the management of medically unexplained symptoms: chronic pain and fatigue, www.guidelines.gov/summary/ summary.aspx?doc_id=3415&nbr=2641 (accessed 2006 Mar 15).
19. World Health Organization. WHO's pain ladder, www.who.int/cancer/ palliative/painladder/en/ (accessed 2006 Mar 15).
20. Drug Enforcement Administration. Mid-level practitioners authorization by state. www.deadiversion.usdoj.gov/drugreg/practioners/index.html (accessed 2006 Oct 10).
21. McCaffery M, Beebe A. Pain: clinical manual for nursing practice. St. Louis: Mosby; 1989.